Dosage, Insurance and White Paper - Pharmacy Technician Pulse

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Dosage

Insurance

White Paper

FDA approves label updates for BMS’ CAR T cell therapies

Pharmaceutical Technology

JUNE 27, 2025

Last month, European Commission approved the new subcutaneous (SC) formulation of Bristol Myers Squibb’s (BMS) Opdivo (nivolumab) with a dosage strength of 600 mg/vial, expanding treatment options for various adult solid tumours. Sign up for our daily news round-up! Give your business an edge with our leading industry insights.

Labelling

Labelling FDA Packaging Communication

A Systemwide Approach to Managing the Risks of Continuous Manufacturing

ISPE

JULY 6, 2023

For much of the pharmaceutical industry, batch manufacturing (BM) processes that have been relied upon for decades remain the preferred approach for most oral solid dosage (OSD) drug products. Office of Pharmaceutical Quality (OPQ) White Paper. 2 1 US Treasury, Office of the Comptroller of the Currency. Final Rule. March 2023.

Insurance

Insurance Documentation Pharmaceutical Companies Pharmaceutical Companies

FDA approves label updates for BMS’ CAR T cell therapies

A Systemwide Approach to Managing the Risks of Continuous Manufacturing

Stay Connected